Cambridge Institute for Medical Research and Department of Medicine, University of Cambridge School of Clinical Medicine, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0XY, UK.
Laboratory of Lymphocyte Signalling and Development, Babraham Institute, Cambridge, CB22 3AT, UK.
J Immunol. 2013 Sep 15;191(6):3037-3048. doi: 10.4049/jimmunol.1301289. Epub 2013 Aug 19.
MicroRNAs (MiRs) are small, noncoding RNAs that regulate gene expression posttranscriptionally. In this study, we show that MiR-210 is induced by Oct-2, a key transcriptional mediator of B cell activation. Germline deletion of MiR-210 results in the development of autoantibodies from 5 mo of age. Overexpression of MiR-210 in vivo resulted in cell autonomous expansion of the B1 lineage and impaired fitness of B2 cells. Mice overexpressing MiR-210 exhibited impaired class-switched Ab responses, a finding confirmed in wild-type B cells transfected with a MiR-210 mimic. In vitro studies demonstrated defects in cellular proliferation and cell cycle entry, which were consistent with the transcriptomic analysis demonstrating downregulation of genes involved in cellular proliferation and B cell activation. These findings indicate that Oct-2 induction of MiR-210 provides a novel inhibitory mechanism for the control of B cells and autoantibody production.
微小 RNA(miRs)是一种小型非编码 RNA,可在后转录水平上调节基因表达。在这项研究中,我们表明 MiR-210 是由 Oct-2 诱导的,Oct-2 是 B 细胞激活的关键转录中介物。MiR-210 的种系缺失导致自身抗体从 5 月龄开始产生。体内过表达 MiR-210 导致 B1 谱系的细胞自主扩增和 B2 细胞适应性受损。过表达 MiR-210 的小鼠表现出类别转换 Ab 反应受损,这一发现在转染 MiR-210 模拟物的野生型 B 细胞中得到证实。体外研究表明细胞增殖和细胞周期进入缺陷,这与转录组分析一致,表明参与细胞增殖和 B 细胞激活的基因下调。这些发现表明,Oct-2 诱导的 MiR-210 为控制 B 细胞和自身抗体产生提供了一种新的抑制机制。